During the past decade, Swietokrzyskie Centrum Onkologii conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 3 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 3 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Swietokrzyskie Centrum Onkologii" #1 sponsor was "Janssen Research & Development, LLC" with 6 trials, followed by "Bayer" with 2 trials sponsored, "Ipsen" with 2 trials sponsored, "Fadoi Foundation, Italy" with 1 trials sponsored and "Ferring Pharmaceuticals" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Swietokrzyskie Centrum Onkologii" #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Medivation, Inc." with 1 trials as a collaborator, "Memorial Sloan Kettering Cancer Center" with 1 trials as a collaborator and "Pharmacyclics LLC." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Swietokrzyskie Centrum Onkologii" are "Prostate Cancer" (4 trials), "Multiple Myeloma" (3 trials), "Carcinoma, Squamous Cell" (1 trials), "Carcinoma, Squamous Cell of Head and Neck" (1 trials) and "Carcinoma, Transitional Cell" (1 trials). Many other conditions were trialed in "Swietokrzyskie Centrum Onkologii" in a lesser frequency.

Most popular intervention types in "Swietokrzyskie Centrum Onkologii" are "Drug" (16 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Daratumumab" (4 trials), "Dexamethasone" (4 trials), "Bortezomib" (3 trials), "Lenalidomide" (3 trials) and "Pomalidomide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Swietokrzyskie Centrum Onkologii" are 11 trials for "All" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Swietokrzyskie Centrum Onkologii". undefined are not yet recruiting, 7 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Swietokrzyskie Centrum Onkologii, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Swietokrzyskie Centrum Onkologii, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Swietokrzyskie Centrum Onkologii has several departments that took part in Clinical trials: "Świętokrzyskie Centrum Onkologii; Dział Chemioterapii" - 4 trials, "Klinika Hematologii i Transplantacji Szpiku, Świętokrzyskie Centrum Onkologii" - 2 trials